Navigation Links
NeurogesX Receives Notice of Allowance for Patent Covering NGX-1998 Capsaicin Topical Liquid
Date:4/28/2011

ass="discStyle" type="disc">
  • Patents relating to capsaicin prodrugs entitled, "TRPV1 Agonist Compounds and Methods for Making and Using the Same," have issued in the United Stated and Mexico.

    • Patents relating to capsaicin oils entitled, "Oils of Capsaicinoids and Methods of Making and Using the Same," have issued in the United States, throughout Europe and Eurasia.

    • With respect to the skin cleansing gel, which is a component of the Qutenza treatment kit and is used to remove residual capsaicin from the skin after a Qutenza treatment, patents entitled, "Compositions and Kits for the Removal of Irritating Compounds from Bodily Surfaces," have issued in Eurasia and Japan.  

    • A patent relating to a capsaicin patch including specific penetration enhancers entitled, "Device for Delivery of TRPV1 Agonists," has issued in South Africa.

    About NeurogesX, Inc.

    NeurogesX, Inc. (Nasdaq: NGSX) is a San Francisco Bay Area-based biopharmaceutical company focused on developing and commercializing novel pain management therapies. NeurogesX was founded on the concept that use of prescription-strength capsaicin could help manage the pain associated with neuropathic pain conditions. Since its inception, NeurogesX has leveraged its passion to help people with pain to efficiently develop this concept, resulting in the commercial launch of Qutenza® (capsaicin) 8% patch in 2010. The Company continues to apply its knowledge and expertise in the development of other novel treatments for pain.

    The Company's lead product, Qutenza®, is a localized dermal delivery system containing prescription strength capsaicin that is currently approved in the United States and the European Union. Qutenza&#
    '/>"/>

    SOURCE NeurogesX
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
    2. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
    3. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
    4. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
    5. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
    6. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
    7. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
    8. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
    9. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
    10. NeurogesX to Present at JMP Securities Healthcare Focus Conference
    11. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... 19, 2014 Research ... the addition of the "Global Gynecological ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... classified into wide categories based on their ... treatment of different gynecological conditions that affect ...
    (Date:9/19/2014)... CHICAGO , Sept. 19, 2014  4WEB Medical ... of 3D-printed foot and ankle osteotomy implants on ... and Ankle Society annual meeting in Chicago ... for all of a surgeon,s osteotomy needs with 74 size ... wedge systems had smaller offerings of only 15 to 18 ...
    (Date:9/19/2014)... , Sept. 19, 2014 UBM Medica US ... leading online community to help oncologists and other clinicians ... regarding the use of targeted therapies and immunotherapies, discusses ... and treatment.  Every September, Blood ... to raise awareness about blood cancers—helping to increase survival ...
    Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 34WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4
    ... Journal of Medicine Study Questions Value of Knee ... new study,questioning the usefulness of arthroscopic surgery for ... physical therapy as an,effective non-surgical option, according to ... published in the September 11 issue of,the New ...
    ... Vanda,Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates,for central nervous system disorders, reported today ... 2008 and discuss the iloperidone non-approvable action,letter that ... Vanda presented arguments to support its belief that ...
    Cached Medicine Technology:New Research Shows Physical Therapy as Effective as Arthroscopic Knee Surgery 2New Research Shows Physical Therapy as Effective as Arthroscopic Knee Surgery 3Vanda Pharmaceuticals Provides Update on Iloperidone 2Vanda Pharmaceuticals Provides Update on Iloperidone 3
    (Date:9/21/2014)... Colorado (PRWEB) September 21, 2014 High ... ten teams of disabled and able-bodied athletes rafted the ... completed a ropes course in pursuit of outdoor adventure. ... from national non-profit World T.E.A.M. Sports, disabilities proved to ... who successfully completed the three stage event. , Each ...
    (Date:9/21/2014)... 2014 “Cluster headaches are sometimes called ... difficult to resolve,” said Steve Young of Ew Publishing; ... a pain that is more intense.” , “It should ... headaches, or migraines, that medical research is pointing to ... he added. , Serotonin (5-HT, 5-hydroxytryptamine) is a ubiquitous ...
    (Date:9/21/2014)... Faculty and staff at Garrison Forest School ... Owings Mills, Md., kicked off the academic year by taking ... is the first independent school to receive the bands— which ... sleep patterns— as part of a pilot program with ... specialty chain. The Vivofit bands are just one tool in ...
    (Date:9/21/2014)... Top10BestSEOHosting.com, a leading review website, ... GreenGeeks are the most recommended hosting suppliers for ... quality hosting products. , “Don’t waste your ... recommend two great hosting companies to you,” the ... iPage and GreenGeeks are the most recommended suppliers ...
    (Date:9/20/2014)... Las Vegas, NV (PRWEB) September 21, 2014 ... created by Dr. Kenneth Pullman that is helping thousands ... reverse their diabetes symptoms without shots, pills, or prescriptions ... investigative review. , “There are currently tens of ... with both Type 1 and Type 2 diabetes, and ...
    Breaking Medicine News(10 mins):Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Garrison Forest School Leader in Independent School Wellness Programs 2Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2
    ... report that mother to be who are obese and ... of their unborn babies., ,Researchers examined the possible ... // - primary caesarean delivery, pre-term birth and low ... J. Rosenberg of Medical Health and Research Association (MHRA), ...
    ... reported in the latest issue of American Journal of ... Infection can cause significant changes in the brain structures ... learning new things, problem solving, paying attention to something ... the conditions happen simultaneously., ,Methamphetamine abuse is linked ...
    ... that can extend the lifespan of mice by as much as ... premature aging around 3 to 4 weeks of age and die ... span of 2 years. This has indeed opened up new avenues ... brain and kidney in some animal species, which then leaks into ...
    ... edition of The Lancet had found the drug artesunate ... common drug quinine., ,Quinine is the only drug ... Africa, South America, and most of Asia. But even ... mortality from severe malaria remains high. Intravenous artesunate is ...
    ... Lucknow, Aug 26 . Japanese encephalitis deaths continue to rise ... 220 in less than a month. //, ,Dr.T.N.Dhole from ... Medical Sciences blamed "official apathy" for the unabated spread ... Uttar Pradesh for nearly three decades., ,Encephalitis is a ...
    ... that all the efforts to curb he disease of sleeping ... reported in this week’s issue of The Lancet., ,The ... Uganda began in 1998 as a result of the movement ... to spread. Interventions to control the disease were put in ...
    Cached Medicine News:Health News:Obesity, diabetes in pregnant women affects babies 2Health News:Changes In Brain Structure From Methamphetamine Abuse And HIV Infection 2Health News:Encephalitis Deaths Cross 220 in Uttar Pradesh 2
    Double ended with 0.5mm x 10mm and 1.0mm x 15mm blades; both blades gently curved; round serrated handle, In Titanium....
    0.6mm Tip x10mm Shaft, Straight Shaft, 90 Degree Hook at Tip; overall length 120mm; in Titianium....
    ... Catheter is indicated for balloon ... of a coronary artery or ... purpose of improving myocardial perfusion. ... also designed to provide distal ...
    16mm from Mid-screw to Tips, blunt tips; overall length 110mm; Stainless Steel...
    Medicine Products: